Floatz logo

Insulin Detemir

Cystic Fibrosis Related Diabetes

Nationwide Children's Hospitalprotein_peptidePhase 2/3Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cystic Fibrosis Related Diabetes cohort.

Asset / SponsorPhaseRating
Glargine Insulin
University of Minnesota
Phase 3BB
Insulin Detemir [Rdna Origin]
Nationwide Children's Hospital
Phase 2/3CCC
REPAGLINIDE
Arbelaez, Ana Maria
N/AD

Same molecule, other indications

Insulin Detemir is also rated in:

type 2 diabetes mellitusDormant
BB
Indicative ·
67 / 100
View asset →
diabetes mellitusDormant
BB
Indicative ·
67 / 100
View asset →
type 2 diabetes mellitusDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →